Not checked for notices yet.
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma
Shuo Qie, Akihiro Yoshida, Stuart Parnham and 8 more
Nature Communications · 2019
doi:10.1038/s41467-019-09179-w
Cited by papers we hold 3
- GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy · 2021No notice
- A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer · 2020No notice
- Targeting mTOR and Metabolism in Cancer: Lessons and Innovations · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.